Integra LifeSciences Holdings Corporation (IART) earnings
IART earnings moved a median of +0.21% by the close. Quarterly and annual IART reports and results, each read against the price at its own news timestamp. Back to the IART overview →
31 measured IART earnings events.
Where these IART earnings landedvs 31 measured IART earnings reactions
| Middle 50% of IART earnings reactions | -4.47% to +2.80% |
|---|---|
| Median reaction (to close) | +0.21% |
| Measured reactions | 31 |
Point-in-time · zero look-ahead
Half of the 31 IART earnings events with a measured close landed between -4.47% and +2.80%; 52% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026 | Press release | -0.22% | -0.67% | |
| Integra LifeSciences Announces Preliminary Third Quarter Results and Updates Full-Year 2026 Guidance | Press release | +3.92% | -4.52% | |
| Form 10-Q INTEGRA LIFESCIENCES For: Jun 30 | SEC filing · Form 10-Q | +3.88% | +3.82% | |
| Integra LifeSciences Reports Second Quarter 2026 Financial Results | Press release | -1.91% | -11.53% | |
| Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026 | Press release | +1.50% | +4.25% | |
| Form 10-Q INTEGRA LIFESCIENCES For: Mar 31 | SEC filing · Form 10-Q | +1.13% | +5.66% | |
| Integra LifeSciences Reports First Quarter 2026 Financial Results | Press release | +4.01% | +8.10% | |
| Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026 | Press release | +0.41% | +1.73% | |
| Form 10-K INTEGRA LIFESCIENCES For: Dec 31 | SEC filing · Form 10-K | +0.85% | +2.34% | |
| Form 10-Q INTEGRA LIFESCIENCES For: Sep 30 | SEC filing · Form 10-Q | +2.56% | +2.47% | |
| Integra LifeSciences Reports Third Quarter 2025 Financial Results | Press release | -7.06% | -22.46% | |
| Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025 | Press release | -0.48% | -1.73% | |
| Form 10-Q INTEGRA LIFESCIENCES For: Jun 30 | SEC filing · Form 10-Q | -4.40% | -3.22% | |
| Integra LifeSciences Reports Second Quarter 2025 Financial Results | Press release | +5.61% | +0.30% | |
| Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025 | Press release | -1.05% | -5.09% | |
| Form 10-Q INTEGRA LIFESCIENCES For: Mar 31 | SEC filing · Form 10-Q | +2.62% | -4.42% | |
| Integra LifeSciences Reports First Quarter 2025 Financial Results | Press release | -13.12% | -10.21% | |
| Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025 | Press release | -0.96% | -2.31% | |
| Form 10-K INTEGRA LIFESCIENCES For: Dec 31 | SEC filing · Form 10-K | -1.53% | -3.67% | |
| Form 10-Q INTEGRA LIFESCIENCES For: Sep 30 | SEC filing · Form 10-Q | +2.13% | +3.79% | |
| Integra LifeSciences Reports Third Quarter 2024 Financial Results | Press release | +2.23% | +9.64% | |
| Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024 | Press release | -1.20% | +0.21% | |
| Form 10-Q INTEGRA LIFESCIENCES For: Jun 30 | SEC filing · Form 10-Q | +2.15% | +1.34% | |
| Integra LifeSciences Reports Second Quarter 2024 Financial Results | Press release | -3.34% | +3.12% | |
| Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024 | Press release | -1.66% | -1.23% | |
| Form 10-Q INTEGRA LIFESCIENCES For: Mar 31 | SEC filing · Form 10-Q | +2.96% | +10.83% | |
| Integra LifeSciences Reports First Quarter 2024 Financial Results | Press release | -7.89% | -21.61% | |
| Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024 | Press release | -1.49% | -9.15% | |
| Form 10-K INTEGRA LIFESCIENCES For: Dec 31 | SEC filing · Form 10-K | -0.72% | -5.36% | |
| Form 10-Q INTEGRA LIFESCIENCES For: Sep 30 | SEC filing · Form 10-Q | +0.88% | +1.37% | |
| Integra LifeSciences Reports Third Quarter 2023 Financial Results | Press release | -2.11% | +0.87% |
Keep exploring
More IART: analyst actions → · SEC filings → · IART overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Defiance Daily Target 2x Long LMND ETF (LMNX) | 844 | +0.07% | 54% |
| NEWLINK GENETICS (NLNK) | 843 | 0.00% | 49% |
| Anavex Life Sciences Corp. (AVXL) | 839 | -0.10% | 46% |
| Assertio Holdings, Inc. (ASRT) | 833 | -0.02% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.